Asia-Pacific Blood Glucose Monitoring Market Size- By Self Monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Asia-Pacific Blood Glucose Monitoring Market Introduction and Overview

According to SPER market research, 'Asia Pacific Blood Glucose Monitoring Market Size - By Self-monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the APAC Blood Glucose Monitoring Market is predicted to reach USD 7.53 billion by 2033 with a CAGR of 7.98%.

Blood glucose monitoring devices are used by diabetics to measure and manage their blood glucose levels. These technologies allow patients to check their blood glucose levels quickly and non-invasively. The devices do a quantitative test to determine blood glucose levels. People can control their condition by monitoring blood glucose levels and seeking medical attention when necessary.

The COVID-19 epidemic contributes to the growth of the Asia-Pacific Diabetes Care Devices Market. People with diabetes who test positive for COVID-19 may experience unusual fluctuations in blood sugar, elevated blood sugar, and other diabetes-related problems. The severity and mortality of COVID-19 were significantly higher in people with diabetes, especially in those with poor glycemic control and type 1 (T1DM) or type 2 (T2DM) diabetes mellitus.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Self-monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User

Regions covered China, Japan, Australia, India, Rest of Asia Pacific

Companies Covered Abbott Diabetes Care, Acon, Agamatrix Inc., Arkray, Ascensia Diabetes Care, Bionime Corporation, Dexcom, Johnson and Johnson (Lifescan), Medisana, Medtronic, Roche, Rossmax, Others

Asia Pacific Blood Glucose Monitoring Market Segmentation

By Self-monitoring Blood Glucose Devices: Based on the Self-monitoring Blood Glucose Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Glucometer Devices, Test Strips, Lancets.

By Continuous Glucose Monitoring Devices: Based on the Continuous Glucose Monitoring Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Sensors, Durables.

By End User: Based on the End User, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Hospital/Clinics, Home/Personal.

Product Code: MEDE2411

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Asia-Pacific Blood Glucose Monitoring Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Asia-Pacific Blood Glucose Monitoring Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Asia-Pacific Blood Glucose Monitoring Market

7. Asia-Pacific Blood Glucose Monitoring Market, By Self-monitoring Blood Glucose Devices(USD Million)

7.1. Asia-Pacific Blood Glucose Monitoring Market Value Share and Forecast, By Self-monitoring Blood Glucose Devices, 2024-2033
7.2. Glucometer Devices
7.3. Test Strips
7.4. Lancets

8. Asia-Pacific Blood Glucose Monitoring Market, By Continuous Glucose Monitoring Devices (USD Million)

8.1. Asia-Pacific Blood Glucose Monitoring Market Value Share and Forecast, By Continuous Glucose Monitoring Devices, 2024-2033
8.2. Sensors
8.3. Durables

9. Asia-Pacific Blood Glucose Monitoring Market, By End User (USD Million)

9.1. Asia-Pacific Blood Glucose Monitoring Market Value Share and Forecast, End User, 2024-2033
9.2. Hospital/Clinics
9.3. Home/Personal

10. Asia-Pacific Blood Glucose Monitoring Market Forecast, 2020-2033 (USD Million)

10.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share

11. Asia-Pacific Blood Glucose Monitoring Market, By Self-monitoring Blood Glucose Devices, 2020-2033 (USD Million)

11.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Self-monitoring Blood Glucose Devices (2020-2026)
11.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Self-monitoring Blood Glucose Devices (2027-2033)

12. Asia-Pacific Blood Glucose Monitoring Market, By Continuous Glucose Monitoring Devices , 2020-2033 (USD Million)

12.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Continuous Glucose Monitoring Devices (2020-2026)
12.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Continuous Glucose Monitoring Devices (2027-2033)

13. Asia-Pacific Blood Glucose Monitoring Market, End User, 2020-2033 (USD Million)

13.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By End User (2020-2026)
13.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By End User (2027-2033)

14. Asia-Pacific Blood Glucose Monitoring Market, By Region, 2020-2033 (USD Million)

14.1. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Region (2020-2026)
14.2. Asia-Pacific Blood Glucose Monitoring Market Size and Market Share By Region (2027-2033)
14.3. China
14.4. Japan
14.5. Australia
14.6. India
14.7. Rest of Asia Pacific

15. Company Profile

15.1. Abbott Diabetes Care
- 15.1.1. Company details
- 15.1.2. Financial outlook
- 15.1.3. Product summary
- 15.1.4. Recent developments
15.2. Acon
- 15.2.1. Company details
- 15.2.2. Financial outlook
- 15.2.3. Product summary
- 15.2.4. Recent developments
15.3. Agamatrix Inc.
- 15.3.1. Company details
- 15.3.2. Financial outlook
- 15.3.3. Product summary
- 15.3.4. Recent developments
15.4. Arkray
- 15.4.1. Company details
- 15.4.2. Financial outlook
- 15.4.3. Product summary
- 15.4.4. Recent developments
15.5. Ascensia Diabetes Care
- 15.5.1. Company details
- 15.5.2. Financial outlook
- 15.5.3. Product summary
- 15.5.4. Recent developments
15.6. Bionime Corporation
- 15.6.1. Company details
- 15.6.2. Financial outlook
- 15.6.3. Product summary
- 15.6.4. Recent developments
15.7. Dexcom
- 15.7.1. Company details
- 15.7.2. Financial outlook
- 15.7.3. Product summary
- 15.7.4. Recent developments
15.8. Johnson and Johnson (Lifescan)
- 15.8.1. Company details
- 15.8.2. Financial outlook
- 15.8.3. Product summary
- 15.8.4. Recent developments
15.9. Medisana
- 15.9.1. Company details
- 15.9.2. Financial outlook
- 15.9.3. Product summary
- 15.9.4. Recent developments
15.10. Medtronic
- 15.10.1. Company details
- 15.10.2. Financial outlook
- 15.10.3. Product summary
- 15.10.4. Recent developments
15.11. Roche
- 15.11.1. Company details
- 15.11.2. Financial outlook
- 15.11.3. Product summary
- 15.11.4. Recent developments
15.12. Rossmax
- 15.12.1. Company details
- 15.12.2. Financial outlook
- 15.12.3. Product summary
- 15.12.4. Recent developments
15.13. Others